Shanghai Fosun Pharmaceutical News

Announcement on the proposed sale of 6.01% of the equity interest in Gland Pharma Limited, a subsidiary in which Fosun Pharma holds controlling equity interests.

Jun 20 00:00

Announcement on the Progress of Fosun Pharma's Repurchase of Shares through Concentrated Bidding Trading

Jun 5 00:00

Announcement of Fosun Pharmaceutical on increasing its shareholding in Foshan Xinglian Nursing Home Co., Ltd. and related transactions

Jun 1 00:00

Fosun Pharmaceutical's Announcement on Shareholders' Partial Shares Pledges and Cancellation of Pledges

May 28 00:00

Fosun Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding

May 7 00:00

Fosun Pharmaceuticals: China International Finance Co., Ltd. summary report on the continuous supervision and sponsorship of the non-public offering of A-shares by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Apr 13 00:00

Fosun Pharmaceutical's progress announcement on the repurchase of shares through centralized bidding

Apr 3 00:00

Announcement of Fosun Pharmaceutical\'s 2023 Profit Distribution Plan

Mar 27 00:00

Fosun Pharmaceutical\'s Announcement and Repurchase Report on the Plan to Repurchase Shares Using Centralized Bidding Transactions

Mar 27 00:00

Fosun Pharmaceutical's announcement on the cancellation of the pledge of some shareholders' shares

Mar 21 00:00

Fosun Pharmaceutical's announcement on the progress of implementation of the controlling shareholders' holdings increase plan

Mar 13 00:00

Fosun Pharmaceutical's Announcement on the Chairman's Proposal to Repurchase Shares and the “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan

Mar 2 00:00

Fosun Pharmaceutical\'s 2022 Restricted A-share Incentive Plan grants the first installment of the A-share restricted shares involved in the announcement of the lifting of sales restrictions and listing

Jan 11 00:00

Legal Opinion of Attorney Guo Hao (Shanghai) Office on matters relating to the lifting of sales restrictions during the first lifting of the sales restriction period in the 2022 Restricted A-share Stock Incentive Plan of Shanghai Fosun Pharmaceutical (Grou

Jan 10 00:00

Fosun Pharmaceuticals Supervisory Board\'s inspection opinions on matters relating to the lifting of sales restrictions for the first phase of A-share restricted shares involved in the first phase of the 2022 restricted A-share incentive plan

Jan 10 00:00

Fosun Pharmaceutical\'s Reminder Notice on the Controlling Shareholders\' Shareholding Increase Plan

Nov 25, 2023 00:00

Fosun Pharmaceutical\'s announcement on the implementation of cancellation of some restricted A-share repurchases

Nov 21, 2023 00:00

Legal Opinion of Law Guohao (Shanghai) Firm on the implementation of some restricted stock repurchase cancellations in the 2022 restricted A-share stock incentive plan of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Nov 21, 2023 00:00

Fosun Pharmaceutical\'s announcement on increasing equity holdings in Shanghai Fujian Equity Investment Fund Management Co., Ltd. and related transactions

Oct 31, 2023 00:00

Legal opinion of Mr. Guo Hao (Shanghai) Firm on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.\'s 2022 restricted A-share incentive plan, repurchase and cancellation of some restricted shares

Sep 28, 2023 00:00